A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children

• Status: Completed
• Trial end date: 2015-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate how much of the LY2801653 drug is available in the body when given in 2 different formulations with and without a meal to healthy participants who are not able to have children. In addition, this study will measure how much of the drug gets into the blood stream and how long it takes the body to get rid of it. Information about any side effects that may occur will also be collected. The study will last about 27 days. Screening is required within 28 days prior to the start of the study.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Niacinamide

Criteria

Inclusion Criteria:

• Generally healthy sterile male and female participants

• Body mass index (BMI) of 18.0 to 32.0 kilograms per square meter (kg/m^2), inclusive

• Are willing and able to eat the protocol specified high-fat breakfast

Exclusion Criteria:

• Have consumed grapefruits or grapefruit-containing products, Seville oranges or Seville orange juice, star fruit, star fruit juice, or star fruit-containing products, or commercial apple or orange juice within 14 days prior to first dosing

• Regularly use known drugs of abuse and/or show positive findings on urinary drug screening

• Have donated blood of more than 500 milliliter (mL) within the last month